EQRIVY

Serial Number 90236295
606

Registration Progress

Application Filed
Oct 5, 2020
Under Examination
Nov 16, 2021
Approved for Publication
Sep 21, 2021
Published for Opposition
Sep 21, 2021
Registered

Trademark Image

EQRIVY

Basic Information

Serial Number
90236295
Filing Date
October 5, 2020
Published for Opposition
September 21, 2021
Abandonment Date
December 16, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 16, 2024
Classes
005

Rights Holder

ADC Therapeutics SA

99
Address
Route de la Corniche, 3B
Epalinges 1066
CH

Ownership History

ADC Therapeutics SA

Original Applicant
99
Epalinges CH

ADC Therapeutics SA

Owner at Publication
99
Epalinges CH

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

36 events
Date Code Type Description Documents
Dec 16, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 16, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 14, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 14, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 14, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 17, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 15, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 15, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 15, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 24, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 22, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 22, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 22, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 22, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 20, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 20, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 20, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 23, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 21, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 21, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 21, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 16, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 21, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 21, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 1, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 18, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 21, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 20, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 20, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 3, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 3, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 3, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 2, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 19, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 8, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology

Classification

International Classes
005